13-valent pneumococcal vaccine: 50 years of age and older
Prescrire International 22(135): 38
2013
ISSN/ISBN: 1167-7422 PMID: 23444498 Document Number: 670161
In adults, the 13-valent pneumococcal conjugate vaccine seems to be more immunogenic than the 23-valent polysaccharide pneumococcal vaccine for most of the 12 shared serotypes. However, in mid-2012, routine vaccination of adults has no proven efficacy.
Document emailed within 1 workday
Related Documents
Vernacchio, L.; Neufeld, E.J.; Macdonald, K.; Kurth, S.; Murakami, S.; Hohne, C.; King, M.; Molrine, D. 1998: Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease Journal of Pediatrics 133(2): 275-278Hak, E.; Grobbee, D.E.; Sanders, E.A.M.; Verheij, T.J.M.; Bolkenbaas, M.; Huijts, S.M.; Gruber, W.C.; Tansey, S.; McDonough, A.; Thoma, B.; Patterson, S.; van Alphen, A.J.; Bonten, M.J.M. 2008: Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults Netherlands Journal of Medicine 66(9): 378-383
Vyse, A.; Campling, J.; Czudek, C.; Ellsbury, G.; Slack, M. 2020: The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development Vaccine 38(51): 8068-8070
Doherty, M.J.; Greenstone, M.A.; Meigh, R. 1997: Pneumococcal vaccine campaign based in general practice. Small audit showed that only 14% of patients were offered pneumococcal vaccine Bmj 315(7111): 816
1996: Belgian consensus on pneumococcal vaccine. Working Party on Pneumococcal Vaccine Acta Clinica Belgica 51(5): 350-356
Shiri, T.; Auranen, K.; Nunes, M.C.; Adrian, P.V.; van Niekerk, N.; de Gouveia, L.; von Gottberg, A.; Klugman, K.P.; Madhi, S.A. 2013: Dynamics of pneumococcal transmission in vaccine-naive children and their HIV-infected or HIV-uninfected mothers during the first 2 years of life American journal of epidemiology 178(11): 1629-1637
Joura, E.A.; Giuliano, A.R.; Iversen, O-Erik.; Bouchard, C.; Mao, C.; Mehlsen, J.; Moreira, E.D.; Ngan, Y.; Petersen, L.Kjeld.; Lazcano-Ponce, E.; Pitisuttithum, P.; Restrepo, J.Alberto.; Stuart, G.; Woelber, L.; Yang, Y.Cheng.; Cuzick, J.; Garland, S.M.; Huh, W.; Kjaer, S.K.; Bautista, O.M.; Chan, I.S.F.; Chen, J.; Gesser, R.; Moeller, E.; Ritter, M.; Vuocolo, S.; Luxembourg, A.; Chan, I.; Chen, J.; Cuzick, J.; Gesser, R.; Luxembourg, A.; Gesser, R.; Giuliano, A.; Iversen, O.E.; Joura, E.; Kjaer, S.K.; Lazcano, E.; Mao, C.; Mehlsen, J.; Moeller, E.; Moreira, E.; Ngan, Y.; Petersen, L.; Pitisuttithum, P.; Restrepo, J.; Ritter 2015: A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women New England Journal of Medicine 372(8): 711-723
Aker, M.; Amitai, I.; Hass, H. 1983: Failure of pneumococcal vaccine to prevent pneumococcal meningitis Harefuah 105(7): 164
Brandstetter, R.D.; Kaplowitz, I.; Pugliese, A.; Andresen, A.; Phillips, E. 1991: Fatal pneumococcal infection: another plea for the pneumococcal vaccine New York State Journal of Medicine 91(1): 36
Austrian, R. 1988: Correction: pneumococcal vaccine and pneumococcal pneumonia Annals of Internal Medicine 109(9): 762-763
Libwea, J.N.; Kobela, M.; Ollgren, J.; Emah, I.; Tchio, R.; Nohynek, H. 2014: Predictors to parental knowledge about childhood immunisation/EPi vaccines in two health districts in Cameroon prior to the introduction of 13-valent Pneumococcal Conjugate Vaccines (PCV-13) Pan African Medical Journal 17: 187
Lue, C.; Tarkowski, A.; Mestecky, J. 1988: Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies Journal of Immunology 140(11): 3793-3800
Lue, C.; Tarkowski, A.; Mestecky, J. 1988: Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies Journal of Immunology 140(11): 3793-3800
Garg, M.; Kaplan, A.M.; Bondada, S. 1994: Cellular basis of differential responsiveness of lymph nodes and spleen to 23-valent Pnu-Imune vaccine Journal of Immunology 152(4): 1589-1596
Austrian, R. 1981: Pneumococcal pneumonia and pneumococcal vaccine Mount Sinai Journal of Medicine new York 48(6): 532-538
Miiro, G.; Kayhty, H.; Watera, C.; Tolmie, H.; Whitworth, J.A.G.; Gilks, C.F.; French, N. 2005: Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine Journal of Infectious Diseases 192(10): 1801-1805
Wilhelmson, B. 1995: Pneumococcal vaccine for children prior the year of 2000. Promising data on vaccine candidates Lakartidningen 92(41): 3781-3782
Sgambatti, S.; Minamisava, R.; Afonso, E.T.; Toscano, C.M.; Bierrenbach, A.L.; Andrade, A.L. 2015: Appropriateness of administrative data for vaccine impact evaluation: the case of pneumonia hospitalizations and pneumococcal vaccine in Brazil Epidemiology and Infection 143(2): 334-342
Madhi, S.A.; Bamford, L.; Ngcobo, N. 2014: Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme South African Medical Journal 104(3 Suppl. 1): 228-234
Root, E.D.; Lucero, M.; Nohynek, H.; Anthamatten, P.; Thomas, D.S.K.; Tallo, V.; Tanskanen, A.; Quiambao, B.P.; Puumalainen, T.; Lupisan, S.P.; Ruutu, P.; Ladesma, E.; Williams, G.M.; Riley, I.; Simões, E.A.F. 2014: Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children Proceedings of the National Academy of Sciences of the United States of America 111(9): 3520-3525